BeammWave (Q3 Review): Period of digestion - Redeye

Redeye notes that BeammWave’s Q3 2025 report was in line with its EBITDA forecast, due to OPEX being 10% lower than expected, although capitalised costs were SEK0.9m below forecast. Following a capital raise that netted SEK79m, BeammWave holds a cash position of SEK93m. Redeye believes news flow will be limited ahead of the tape-out, as the company focuses on supporting existing customers, advancing its roadmap, and completing the chip's industrialisation. Redeye adjusts its Base Case from SEK12 to SEK11.

Länk till analysen i sin helhet: https://www.redeye.se/research/1138387/beammwave-q3-review-period-of-digestion?utm_source=finwire&utm_medium=RSS